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Abstract: 1	
As obesity rates continue to climb, the notion that overconsumption reflects an underlying ‘food 2	
addiction’ (FA) has become increasingly influential. One theory is that sugar acts as an addictive agent, eliciting 3	
neurobiological changes similar to those seen in drug addiction. In this paper, we review the evidence 4	
supporting sugar addiction. We begin by considering the addictiveness of highly processed foods, particularly 5	
those with high sugar content. We then investigate the addictive potential of sugar by contrasting evidence from 6	
the animal and human neuroscience literature on drug and sugar addiction. Limitations of prominent self-report 7	
measures of FA are also discussed. We conclude that there is little evidence to support sugar addiction in 8	
humans, and findings from the animal literature suggest that addiction-like behaviours, such as bingeing, occur 9	
only in the context of intermittent access to sugar. These behaviours likely arise from intermittent access to 10	
sweet tasting or highly palatable foods, not the neurochemical effects of sugar. Given the lack of evidence, we 11	
argue against a premature incorporation of sugar addiction into the scientific literature and public policy 12	
recommendations. 13	
Key words: Sugar addiction, obesity, binge eating, animal neuroscience, drug addiction  14	
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1. Introduction  1	
Between 1980 and 2013, the proportion of overweight (Body Mass Index (BMI) ≥ 25 kg/m2) and obese 2	
(BMI ≥ 30 kg/m2) adults rose from 28.8% to 36.9% worldwide, with similar trends appearing in children and 3	
adolescents [1]. The accompanying costs of health consequences and absenteeism associated with excess 4	
weight, estimated to range from $3.38 to 6.38 billion annually in the U.S alone, makes obesity a pressing public 5	
health problem [2]. The scale and impact of the obesity pandemic are incontrovertible. The gravity of the 6	
situation demands extreme care and careful scrutiny of existing evidence rather than premature application of 7	
questionable concepts. In this spirit, we wish to evaluate sugar addiction because such a concept could have 8	
remarkable consequences in terms of public policy and health advice if generally accepted. 9	
The food addiction (FA) model asserts that excessive consumption of palatable foods may be understood 10	
within the same neurobiological framework as drug addiction. The model of addiction here is that 11	
operationalized in the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) and one that is widely 12	
accepted in the neuroscientific literature. It is characterised by loss of control of drug consumption, increased 13	
motivation to consume and a persistence of drug taking despite negative consequences, and the neurobiology of 14	
these behaviours has been extensively studied (see [3, 4]). Individuals who develop FA are thought to display 15	
symptoms analogous to those of drug abuse, including loss of control, withdrawal, and cravings for ‘problem 16	
foods’ [5]. Theron Randolph first used the term ‘food addiction’ in 1956 [6] to describe addictive-like 17	
consumption of various foods, such as corn, milk, eggs, and potatoes. However, aspects of the FA model have 18	
changed since this original description (see [7]), and there is an emerging view that highly processed foods, rich 19	
in sugar and fat, are most likely to be addictive. FA researchers argue that examining obesity through the lens of 20	
addiction will open new avenues for prevention, treatment and public health policy [8, 9] though this, like many 21	
other aspects of the model, has been questioned [10, 11].  22	
Sugar addiction represents a specific case of the FA model in which the addictive substance is the specific 23	
nutrient sugar. In this Perspective article, we consider the state of the evidence in support of sugar addiction in 24	
humans and provide a critical review of the preclinical neuroscience research that has identified sugar addiction 25	
in rodent models. This is important because few studies have specifically examined sugar addiction in humans, 26	
and the bulk of supporting evidence comes from animal work. However, there is a methodological challenge in 27	
translating this work because humans rarely consume sugar in isolation. In order to assess the existing evidence, 28	
we must first consider if sugar could be an addictive agent, examining specifically the animal neuroscientific 29	
evidence suggested to support this. As the animal neuroscience of sugar addiction draws strong parallels to drug 30	
	 4	
addiction, we review the sugar and drug addiction neuroscience side by side. We go on to consider the human 1	
model of FA to determine if and how it could be applied to sugar.  2	
2.  Characterising  (potentially) addictive foods 3	
A general view is that FA is similar to substance addictions, rather than non-substance behavioural 4	
addictions outlined in the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5; for a 5	
different perspective, see [12]), in that certain ‘addictive agents’ within food produce neurochemical effects in 6	
the brain similar to drugs of abuse. The Yale Food Addiction Scale (YFAS [13] and recently the YFAS 2.0 7	
[14]), which is now the widely accepted measurement tool for studying FA, enquires about addiction-like eating 8	
behaviours with respect to ‘certain foods.’ These scales do not specify nutrients of interest, yet this is only 9	
reasonable as we usually consume food with multiple nutrients. Even foods that may be predominantly 10	
composed of a single nutrient (e.g. sugar-sweetened beverages) have flavour(s) and other non-nutritive 11	
elements. However, examining the addictive potential of different foods may provide an indication as to 12	
whether any particular nutrient(s) are critical in determining addictive potential.  13	
 Evidence from rodent models supports high-fat [15], high-sugar [16] and, most strongly, combinations 14	
of high-fat and high-sugar [17] foods as candidates for FA. In humans, the FA construct extrapolates this view, 15	
surmising that highly processed, hyperpalatable foods are the ones that have addictive potential [18]. Lack of 16	
knowledge surrounding what might constitute an addictive food poses a substantial challenge, and, to our 17	
knowledge, only two studies have examined the addictive potential of various foods.  18	
Schulte and colleagues [5] suggest that certain highly-processed foods share pharmacokinetic properties 19	
(inasmuch as the term can be used for food), such as high potency and rapid absorption rate, with drugs of 20	
abuse. The authors report that such processed foods are strongly associated with self-reported addictive eating as 21	
measured by the YFAS. Their findings also demonstrate that fat content and glycaemic load (GL, grams of 22	
carbohydrate per serving) predict ratings of problematic foods, where processed foods high in fat and/or GL are 23	
self-reported as more problematic. In this study, highly processed foods were defined as those high in fat and 24	
refined carbohydrates (high GL) that may also contain low levels of fibre, protein, and water content. Schulte et 25	
al. argue that processing of raw foods increases the foods’ ‘potency’, or the absorption of the potential 26	
‘addictive agents’ (e.g., fat, sugar, salt) into the bloodstream, as indexed by spikes in blood glucose levels 27	
following consumption [5].   28	
Fowler et al. hypothesised that individuals who developed substance use disorders post bariatric surgery 29	
would be more likely to have had problems with foods that would cause high postprandial glucose levels [19]. 30	
	 5	
For this, they used foods listed in the YFAS and categorised them based on published glycaemic indices (GI), 1	
fat and sugar content. Findings indicated increased likelihood of post-operative substance use amongst patients 2	
who endorsed high-GI and high-sugar, low-fat (but not high-sugar alone) foods as the most problematic [19]. 3	
Thus, the authors concluded that these patients might have experienced ‘addiction transfer’ resulting from 4	
previously undiagnosed FA. These findings should be interpreted in the light of several limitations. Apart from 5	
the retrospective recall of ‘problem foods’, only two foods (candy and soda pop) were classified as high-sugar 6	
low-fat. Furthermore, analyses of the relationship between problem foods and substance use onset failed to 7	
control for current or previous psychiatric morbidity, success of surgery or current quality of life. Moreover, we 8	
would suggest caution in arguing that such foods are addictive based on the contentious concept of addiction 9	
transfer [20].  10	
To describe the difference between foods such as cupcakes and bananas primarily as being one of degree of 11	
processing is perhaps a rather narrow view, and a strong case can be made for these foods having other 12	
important differences relevant to overconsumption and obesity (e.g., energy density). Even leaving this aside, 13	
there are several important concerns about both of these studies. First, the potentially addictive foods have been 14	
taken from the ‘problem foods’ list of the YFAS. The scale quantifies FA symptoms with respect to these 15	
problem foods, based on the assumption that they are likely to be addictive. Both of the aforementioned studies 16	
rely on this assumption and take the evidence that individuals have reported FA symptoms with respect to these 17	
foods on the YFAS in several studies, as further supporting the assumption. Second, these findings rely entirely 18	
upon participants’ perceptions of difficulties surrounding the foods items, which are then linked (by way of 19	
mechanistic explanation not empirical evidence) via GL or GI to postprandial glucose and insulin. That is, no 20	
direct evidence indicates that these foods are problematic for these individuals because they lead to higher 21	
postprandial glucose. Although individual postprandial glucose response (PPGR) has low intrapersonal 22	
variability, there can be high interpersonal variability in PPGR following the consumption of identical meals 23	
[21, 22]. For example, Zeevi et al. [21] found that PPGRs for cookies and bananas varied significantly across 24	
participants, suggesting that some individuals may be high glucose responders to ‘good’ foods and low 25	
responders to ‘bad’ foods. It is also important to note that there are several high GI foods such as breakfast 26	
cereals and baked potatoes that are not included in the list of YFAS problem foods.  This suggests that the 27	
potential explanatory power of high GI as a determinant of addictive potential would lessen considerably if we 28	
looked beyond the list of problem foods. Given the host of metabolic, endocrine, and physiological factors that 29	
	 6	
affect glucose regulation, it is important to consider the physiological response to foods as an interaction 1	
between the nutrient content of the food and the individual.  2	
Third, and most importantly, the proposed model of why high GI/GL foods may be potentially addictive 3	
lacks a mechanistic link between higher postprandial levels of glucose and addictive potential. Schulte et al. 4	
draw upon a seemingly superficial similarity between the addictive potential of drugs, based on their dose and 5	
speed of absorption, to explain why processed foods are likely to be addictive. Proponents of FA draw parallels 6	
between the processing of grapes to wine, poppies to opium and the coca leaf to cocaine, which demonstrate the 7	
transition from naturally occurring substances/food to drugs of abuse and increasing potency via processing. 8	
Yet, this formulation of highly processed foods only captures the pharmacokinetic aspects of drugs of abuse, 9	
overlooking the critical pharmacodynamic effects. The coca leaf for instance has a pharmacodynamic effect, 10	
which can be enhanced by increasing the dose of the active ingredient through processing.  For sugar or other 11	
foods, studies show that moderate increases in blood glucose following oral glucose ingestion can enhance 12	
cognitive performance in a variety of tasks, including semantic memory retrieval [23], reaction time tasks [24], 13	
and even driving performance [25]. Few functional MRI studies have examined the effect of blood glucose on 14	
brain function as it relates specifically to hedonic eating behaviours; however, Sun et al. [26] report that neither 15	
fasting nor postprandial blood glucose affected the blood-oxygen dependent (BOLD) response to milkshake 16	
taste cues in several brain regions (e.g., amygdala, pallidum, insula) that have been implicated in drug cue 17	
studies. In men, increased postprandial blood glucose levels have been associated with increased resting state 18	
brain activity in regions associated with reward processing [27]. Given the tight physiological control over the 19	
stability of glucose supply to the brain, it is perhaps not unexpected that changes in systemic glucose would not 20	
have large effects on brain function. In short, the notion of increased dosage having increased potency and 21	
thereby increased addictive potential is questionable when it comes to sugar. 22	
2.1 Is sugar a potentially addictive substance?  23	
 The FA literature considers sugar (and other refined carbohydrates) to be a key facet of processed 24	
foods with high addictive potential, contributing to their GL (dose) and their rapid rate of absorption. Within 25	
this context, discussion of sugar has centred on its palatability or hedonic value; however, unlike substances of 26	
abuse, sugar has both hedonic and caloric value, and these two aspects broadly map onto ingestive and post-27	
ingestive effects of its consumption, respectively. Moreover, these aspects are distinct and dissociable in terms 28	
of their neural processing as demonstrated in two elegant sets of experiments. Domingos et al. [28] showed that 29	
melanin-concentrating hormone expressing (MCH) neurons located within the lateral hypothalamus respond to 30	
	 7	
extracellular glucose levels and project to dopaminergic (DA) neurons in the striatum and midbrain regions. The 1	
animals show a preference for sucrose over the non-nutritive sweetener, sucralose, and the glucose-sensing 2	
ability of these neurons is critical in determining this, as transgenic mice lacking MCH neurons do not show this 3	
preference [28]. MCH neurons encode the rewarding nutrient properties of sucrose by increasing striatal DA 4	
release independently of gustatory input. Optogenetic stimulation of MCH neurons during consumption of 5	
sucralose leads to striatal DA efflux and preference for sucralose over sucrose [28].  6	
Recently, Tellez et al. [29] expanded upon this work by examining DA transmission in the striatum in 7	
response to oral sucralose intake versus intra-gastric glucose or sucralose administration. Using microdialysis, 8	
the authors reported changes in DA release in the ventral and dorsal striatum, where regional DA release 9	
selectively encoded the pleasurable and nutritional value of the sweet foods. Sucralose consumption was linked 10	
to enhanced DA efflux in the ventral striatum (VS), which was no longer observed following devaluation of the 11	
sweetener with a bitter additive. Conversely, intra-gastric infusion of glucose, but not sucralose, elicited DA 12	
release in the dorsal striatum DS. Thus, the VS and DS appear to encapsulate functionally distinct responses to 13	
palatable and nutritive signalling, and the authors went on to delineate the role of D1 and D2 striatal DA 14	
neurons in palatability and nutrient preferences. Dopaminergic signalling excites D1 neurons while inhibiting 15	
their D2 counterparts, and this interaction modulates the control of goal-directed actions, including overeating 16	
[30]. Optogenetic stimulation of D1 neurons within the DS and substantia nigra terminals increases 17	
consumption of a bitter sucrose solution, which supports the dorsal basal ganglia pathway as a circuit that is 18	
selectively responsive to the nutrient properties of sugar reward [29]. It should be noted, however, that the role 19	
of MCH, D1, and D2 neurons has yet to be explored in animal models of sugar addiction, so whether the 20	
aforementioned neural circuits reflect processes underlying addictive-like sugar consumption remains unknown. 21	
  This experimental work allows us to consider that addictive-like properties of sugar may occur via 22	
three neural mechanisms: one related to palatability and the reinforcing effects of sweet taste, another related to 23	
caloric value and post-ingestive effects and a third arising from a combination of the two effects. Put simply, the 24	
critical ‘addictive’ quality of sugar may be restricted to its sweetness, nutritional value, or some combination of 25	
the two. Of course, only the third possibility would support sugar as addictive, particularly within Schulte et 26	
al.’s model where highly processed foods with added sugar would be very sweet, energy dense and rapidly 27	
absorbed and therefore potentially have a characteristic profile of ingestive and post-ingestive effects. 28	
Nonetheless, as humans often consume sugar in combination with other nutrients, differences between highly 29	
processed foods with high and low addictive potential would need to be characterised. Indeed, Zeevi et al. [21] 30	
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demonstrated that the same foods can have very different post-ingestive profiles in different individuals. This 1	
may be a critical factor, and one aspect of individual vulnerability to a potentially addictive food. These are 2	
theoretical considerations as thus far there little work in humans has examined them directly. The animal 3	
literature does, however, offer some experimental evidence of parallels between sugar and drugs. We consider 4	
this in the next section, beginning with a brief overview of the neurobiological characteristics of drug addiction.  5	
3. Animal models of drug addiction  6	
Prevailing models of drug addiction emphasize changes in reward-based learning and memory processes as 7	
core mechanisms involved in the transition from voluntary drug use to chronic abuse. Initially, goal-directed 8	
drug use releases DA within the mesolimbic system which reinforces ‘drug taking’ behaviour by increasing the 9	
salience of, and subsequent motivation toward, drug-related cues [31]. Drug taking increases DA in the nucleus 10	
accumbens (NAcc) shell, yet this response becomes blunted over time in a manner that differs from habituation 11	
[32]. Instead, drug-related cues produce an anticipatory DA release in the dorsal striatum (DS), resulting in 12	
strong drug cravings [33]. This has been framed as an increased anticipatory reward with an attenuated 13	
consummatory reward. Activation in the dorsal striatum and basolateral amygdala drives ‘drug seeking’ 14	
behaviour, and, as this behaviour becomes increasingly elicited by drug-related cues, it is ultimately 15	
consolidated as a stimulus-response (S-R) habit [34]. This transition from goal-directed to habitual drug taking 16	
has been studied extensively (see [3, 35]) in rodent models of addiction to cocaine, heroin and alcohol and 17	
strongly resembles the compulsive drug use in humans.  These compulsive behaviours arise from functional 18	
impairment in the prefrontal cortex (increased drug salience, compulsivity), as well as the dorsolateral and 19	
inferior cortices (compromised executive control) [36]. 20	
The onset of drug addiction has been associated with decreased availability of DA D2 receptors in both 21	
humans and non-human primates [37, 38]. These findings relate low DA receptor availability to increased trait 22	
vulnerability to drug abuse; however, it has been argued that chronic drug use reduces the number of DA D2 23	
receptors, thus resulting in a “hypodopaminergic” system [39]. While it is likely that aberrant DA D2 receptor 24	
numbers reflect both cause (trait vulnerability to) and consequence of prolonged drug use, reduced DA D2 25	
receptor availability has been closely tied to withdrawal symptoms and the development of drug tolerance, in 26	
which drug consumption no longer elicits a positive effect but rather mitigates a negative state [40, 41]. 27	
Together with afferent input from the amygdala, these neuronal changes in the striatum (i.e., reduced DA D2 28	
receptors) perpetuate drug use to avoid dysphoria and withdrawal, comprising what Koob and Le Moal [42] 29	
have termed the ‘dark side’ of addiction.  30	
	 9	
Accordingly, in sugar addiction, one could expect to see a similar behavioural and neurobiological 1	
syndrome. Voluntary consumption of sugar under goal-directed control would increase DA release in the 2	
mesolimbic system, enhancing the salience of and motivation for sugar. Over time, sugar seeking and 3	
consumption would become habitual and compulsive with an accompanying shift from ventral to dorsal striatal 4	
control, as well as changes in prefrontal cortical control of these behaviours. These neural adaptations would 5	
serve to perpetuate sugar seeking that may also be driven by the need to avoid withdrawal symptoms. In line 6	
with research of chronic drug use, DA D2 receptor levels may represent a vulnerability marker and also result as 7	
a consequence of excessive sugar intake over time, regardless of BMI status or obesity.  8	
4. Comparison of drug addiction and sugar addiction 9	
Critical to these studies are the experimental designs used to model addiction-like behaviours in rodents. 10	
We believe that a working knowledge of these paradigms and their limitations is necessary to critically examine 11	
the literature on animal models of drug and sugar addiction. Thus, this section will provide an overview of 12	
common paradigms, and we will compare different aspects of drug and sugar addiction within this context. 13	
Comparisons have been drawn between sugar and a variety of illicit drugs, but, for the purpose of this 14	
Perspective article, we have chosen to focus on the neurobiological effects of cocaine, a stimulant that ‘hijacks’ 15	
the dopaminergic system, and heroin, an opiate that acts upon both dopaminergic and endogenous opioid 16	
systems. It is important to point out at the outset that sugar addiction literature is not as extensive as that of drug 17	
addiction literature and therefore not all aspects of addiction have been examined with respect to sugar.  18	
4.1. General overview of experimental models 19	
Drugs:  20	
Rodent models of addiction traditionally frame the drug of choice as a positive reinforcer, which becomes 21	
associated with a pleasurable outcome. A drug is thought to function as a positive reinforcer if the animal’s 22	
response to the agent exceeds the response to a control e.g. saline solution. Typically, animals are trained to self-23	
administer the drug for a short daily session of 1 to 3 hours [43] for 10 to 30 days [44]. For example, rodents 24	
may be trained to self-administer intravenous (IV) cocaine via a lever press or nose poke using a low ratio-25	
requirement where each lever press prompts drug delivery (a fixed ratio 1 (FR1) delivery). Drugs can be 26	
administered orally or intravenously, though it is often preferred to use the route most analogous to drug use in 27	
humans while taking into consideration taste effects. Thus, implanted catheters are usually used for IV infusion 28	
of cocaine and heroin but some studies allow access to an oral cocaine-sucrose solution [45, 46]. It should be 29	
noted that, because many protocols train rodents to self-administer drugs of abuse prior to testing, this approach 30	
	 10	
is insufficient to quantify vulnerability to drug addiction. As such, the use of drug-naïve animals has become 1	
increasingly commonplace. 2	
To model the transition to compulsive ‘drug seeking,’ the rodents are moved to progressive ratio (PR) tasks, 3	
in which they must systematically work harder (i.e. increase the number of lever presses for a single infusion). 4	
Motivation is further measured by “breakpoints,” or the ratio at which the animal is no longer willing to work 5	
for the reward, and it can be augmented by periods of drug abstinence. To examine the degree to which the 6	
animal will work for the drug despite negative consequences—a key feature of drug dependence—the 7	
conditioned stimuli (e.g. lever press) or outcomes are paired with aversive outcomes, such as an electric 8	
footshock or nauseating chemical additive.  Following extensive drug self-administration, rodents display 9	
withdrawal symptoms in response to forced abstinence, as well as dopamine (e.g., sulpiride) and opioid (e.g., 10	
naloxone) antagonists. However, drug-seeking can be extinguished throughout periods of forced deprivation by 11	
replacing the cocaine or heroin infusion with saline (for a complete review, see [47]).  12	
In human addiction habitual drug-seeking and taking behaviour, even following sustained abstinence, is 13	
often elicited by environmental cues, acute stress, or drug exposure. Second-order reinforcement schedules 14	
represent one method by which cue-elicited reinstatement of drug-seeking can be studied in animals [48]. The 15	
drug infusion is paired with an additional conditioned stimulus (e.g., illuminate light, tone) following which 16	
exposure to the conditioned stimulus has been shown to reinstate cocaine-seeking behaviour [49] and morphine 17	
administration [50] following abstinence. More recently, the conditioned place preference (CPP) paradigm has 18	
become a widely used design, in which rodents associate distinct environments with drug and saline infusions. 19	
Following abstinence, re-exposure to these environments, along with drug priming, leads to the reinstatement of 20	
habitual cocaine and heroin seeking behaviour [51], thus modelling the circumstances under which humans 21	
often experience drug relapse.  22	
Sugar: 23	
Although sugar (e.g., sucrose, saccharin, glucose) reinforcement has been widely used as a natural 24	
reward control within drug addiction studies, Hoebel, Avena and colleagues [16] have demonstrated that, under 25	
certain conditions, rats can develop addiction-like behaviours with respect to sugar. After over a decade of sugar 26	
addiction research, Hoebel and colleagues [52] claim to, ‘[…] still use the same basic technique to obtain clear 27	
signs of food dependency by imposing a feeding schedule that repeatedly induces sugar bingeing after a period 28	
of fasting.’  In brief, this technique deprives rodents of food for 12 hours (or in some instances, 16 hours [53]) 29	
and permits free access to food for the subsequent 12 hours, during which the rats may consume either chow or 30	
	 11	
a sugar solution. Sugar is offered as either a 25% glucose solution or a 10% sucrose solution; the latter simulates 1	
a soft drink. For intermittent sugar access, the 12 hour period of food availability begins 4 hours into the dark 2	
cycle so as to increase rodents’ appetite and therefore the likelihood of consuming a novel food[52]. An 3	
important difference between the animals included in these experiments is that, unlike the drug models, which 4	
increasingly use drug-naïve animals, these animals have usually had previous access to sucrose and are selected 5	
for sucrose-preference (e.g., [54]). This raises the possibility of these animals having a vulnerability to 6	
developing this addiction-like syndrome. Rodents kept on this schedule for 3 to 4 weeks begin to develop signs 7	
of addiction, which we review below (see [55] for additional review). It is important to emphasise these 8	
addiction like behaviours are only seen with sugar with intermittent access regimes and not with ad libitum 9	
access. 10	
4.2. Bingeing 11	
Drugs: 12	
Following initial self-administration training, increased access (e.g., 6 hours/day) to cocaine and heroin has 13	
been associated with enhanced, binge-like consumption [56–58]. Rodents with extended access to a low-dose 14	
cocaine infusion develop a binge-like pattern of consumption that increases rapidly at the outset, plateaus and 15	
becomes highly-variable after 24 hours, where increased time between binges may serve to counteract the 16	
drug’s toxic effects [59]. Interestingly, binge-like self-administration of heroin may be moderated by satiety as 17	
food-restricted rodents self-administer the most heroin at the start of the session, but fed rodents self-administer 18	
heroin at a low, stable level throughout the session [58]. The reinforcing effects of both cocaine and heroin are 19	
dose-dependent, and moderate doses have been shown to elicit reinforcing effects without leading to drug 20	
dependence [60]. 21	
Acute IV administration of cocaine preferentially increases extracellular DA in the NAcc shell when 22	
compared to the NAcc core [61] and this is associated with the acute reinforcing effects of cocaine. Heroin, too, 23	
increases DA release in both the ventral tegmental area (VTA) and the NAcc shell; however, this begins with 24	
the activation of mu-opioid receptors (MOR), which triggers a neurochemical cascade that leads to increased 25	
mesolimbic DA release [62, 63]. Mesolimbic DA release elicits hyperactivity and euphoric effects following 26	
cocaine and heroin infusion, respectively. These effects can be inhibited (as evidenced by reduced self-27	
administration) by lesions to the ventral pallidum, as well as D1 receptor blockade in the central nucleus of the 28	
amygdala, in cocaine-conditioned animals [64, 65]. As heroin has high-affinity for MOR and delta-opioid 29	
receptors (DOR), administration of selective MOR and DA agonists has been shown to result in heroin 30	
	 12	
reinforcement that is extinguished following chemical lesioning of DA neurons or microinjections of opioid 1	
receptor antagonists within the VTA [66]. 2	
Sugar: 3	
Binge-like sugar consumption has been observed in rodents under both 24-hour and intermittent 4	
reinforcement schedules, where animals self-administer sugar on an FR1 protocol. Colantuoni et al. [67] 5	
reported that food-deprived rats increased sugar intake within the first hour of access to food, and similar 6	
bingeing patterns occur when rats receive 12-hour access to both sugar and chow [52]. With the same 7	
intermittent reinforcement schedule, sham-fed rodents consume more sucrose than real-feeding controls [68], 8	
although differences are non-significant with repeated consumption. Interestingly, rodents with ad libitum 9	
access to sugar solution consume the food throughout the light phase (or inactive cycle), and total sugar intake 10	
does not differ between rodents with 12-hour versus 24-hour access [16]. Moreover, rats fed daily intermittent 11	
sugar and chow offset sugar consumption by decreasing chow consumption, thus regulating caloric intake and 12	
preventing weight gain [69, 70]. Because rodents with ad libitum sugar access offset caloric intake and meal 13	
size throughout the testing period, Avena et al. [16] concluded that such experimental conditions cannot elicit 14	
sugar dependence. As such, it appears that the intermittent access is critical to the development of binging, as 15	
animals provided ad libitum access to sucrose fail to develop addictive behaviours.  With respect to obesity, it is 16	
worth emphasising that rats on both intermittent and ad libitum access schedules offset chow intake to 17	
compensate for their sucrose intake and to maintain weight stability.  18	
These behavioural data highlight noteworthy differences between sugar and drug bingeing. An 19	
immediately apparent distinction arises from temporal discrepancies related to forced deprivation of sugar 20	
versus drugs of abuse. Despite limited evidence of food restriction increasing vulnerability to chronic cocaine 21	
use [71], rodents increase both cocaine and heroin intake under normal feeding conditions, or those which 22	
maintain rodents at 85% body weight (e.g., [72]). Under such conditions, it is possible to delineate the 23	
reinforcing effects of drugs of abuse versus non-drug rewards; however, these processes become conflated when 24	
sugar is only presented following food restriction. As similar findings are seen in sham-fed rats, it suggests that 25	
sugar bingeing results from the reinforcing effects of a preferred flavour, rather than post-ingestive effects of 26	
sucrose [55]. Under ad libitum conditions, rats dramatically increase cocaine intake initially, and, although 27	
bingeing becomes variable, rats continue to binge throughout the 72-hour period [59]. Minimal restriction of 28	
cocaine self-administration has led to bingeing patterns that converge with an inherent circadian rhythm, as 29	
rodents repeatedly refused to self-administer cocaine during the light phase [73]. Yet, binge-like consumption of 30	
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sugar appears to follow a distinct consummatory pattern with binges occurring early in the food available 1	
period, which likely arises from both homeostatic regulation of feeding behaviour and the presence of palatable 2	
food.    3	
The neurobiology of sucrose reinforcement has largely focused on dopaminergic effects in the NAcc 4	
shell and core. Intermittent sucrose consumption persistently increases extracellular DA in the NAcc shell and 5	
core in response to sugar in both sham [68] and normal feeding [16, 53] schedules. This effect does not appear 6	
in either control or ad libitum sugar access animals, and as with most foods, the DA response to sugar quickly 7	
habituates [74, 75]. Thus, a drug-like DA response to sugar is only observed in the intermittent binging 8	
paradigm, suggesting a critical role of the paradigm. Corwin has raised the possibility that this paradigm 9	
promotes a form of eating under uncertainty because food availability is unpredictable [76, 77].  10	
Infusion of a selective mu-opioid agonist into the NAcc has led to increased consumption of sweet 11	
foods (e.g., chocolate) with identical nutrient profiles, suggesting that increased mu-opioid receptor binding 12	
underpins flavour rather than sucrose preference [78]. Additionally, MOR agonism in the NAcc has enhanced 13	
saccharin intake [79]. Infusion of naltrexone (an opioid antagonist with high MOR affinity) directly into the 14	
NAcc decreased consumption of the preferred flavour, yet systemic injection decreased consumption of both 15	
foods equally. These findings, along with those of Tellez et al. demonstrating distinct neural mechanisms for 16	
sweetness and caloric content, support the role of rewarding effects of sweet taste in this intermittent access 17	
paradigm. Benton [55] and DiLeone et al. [80] have previously argued, the post-ingestive properties of glucose 18	
appear to have little effect on initial consolidation of its rewarding properties. Moreover, neurobiological 19	
changes in the striatum have yet to be reported in the absence of the intermittent sugar binging (i.e., with ad 20	
libitum access to sugar) [67]. In summary, the dopaminergic changes that resemble addiction only occur with 21	
sugar consumption under the intermittent access regime and, without these conditions, the dopaminergic 22	
response to sugar resembles that to other natural rewards. Conversely, cocaine and opiate drugs cause 23	
neurobiological changes within the NAcc and VS that lead to and perpetuate addiction, including changes in D2 24	
DA receptor levels [3] and MOR density and expression [81] following chronic cocaine and opiate 25	
administration, respectively. 26	
4.3. Motivation and substance seeking  27	
Drugs:  28	
 Following initial self-administration training, rodents show increased motivation for cocaine self-29	
administration as evidenced by high breakpoints within PR schedules. Breakpoints may be manipulated by 30	
	 14	
several experimental parameters, including the unit injection dose and restricted access to cocaine. For example, 1	
rats that were allowed access to cocaine 4 times/hour in a 24 hour period during initial self-administration 2	
showed higher breakpoints after 7 days of abstinence when compared to rats that were initially allowed 72-hour 3	
access [82]. Roberts et al. [56] assert that a progressive increase in daily breakpoints is not only dose-dependent, 4	
but also moderated by the speed of the injection. For example, in rodents with a history of cocaine use, animals 5	
that received 3.0 mg/kg doses had significantly higher breakpoints than those that received 1.5 mg/kg doses 6	
[83]. Over several days of testing, speed of initial cocaine infusion significantly altered breakpoints, with higher 7	
breakpoints observed in rodents receiving cocaine infusions over 5 seconds versus those receiving slower 8	
infusions (e.g., 25 or 50 seconds) [84].  9	
Unlike cocaine seeking, the emergence of heroin-seeking behaviour is closely tied to the onset of acute 10	
withdrawal symptoms, which result in increased consumption by way of negative reinforcement (i.e., avoidance 11	
of a dysphoric state). Acute opiate exposure increases pain sensitivity, which worsens with chronic use, and 12	
sensitization of nociceptive systems may be related to the development of drug dependence via negative 13	
reinforcement [58, 85]. Both forced deprivation and opioid antagonists produce a withdrawal syndrome 14	
characterised by teeth-chattering, paw tremors, and erratic activity [81].  15	
Cocaine abstinence increases motivation in rodents initially trained on PR but not FR schedules, 16	
suggesting that the establishment of cocaine as a positive reinforcer powerfully enhances drug seeking after 17	
abstinence [86]. Moreover, Vanderschuren & Everitt [72] demonstrated that presentation of an aversive 18	
footshock does not suppress cocaine-seeking in rodents with a prolonged cocaine self-administration history. 19	
Importantly, the authors assessed drug-seeking behaviour within a heterogeneous seeking-taking chain schedule, 20	
in which seeking and taking cocaine are distinct acts with separate levers. Additionally, pairing both cocaine-21	
sucrose and lemon-sucrose solutions with an aversive lithium chloride injection has been shown to only devalue 22	
the lemon-sucrose solution as rodents maintained the same level of drug-seeking for the cocaine solution [46]. 23	
 Changes in the limbic, cortical, and ventral striatal circuitry mediate the development of drug seeking 24	
behaviour [35]. Lesioning of either dopaminergic circuitry in the basolateral amygdala or glutamatergic circuitry 25	
in the NAcc core alters cocaine seeking [87]. In contrast, lesioning of medial PFC subregions enhances cocaine 26	
seeking [88], likely by way of diminished executive control, as this region projects to the posterior dorsomedial 27	
striatum (pDMS) and reciprocally to the basolateral amygdala [35]. The DA D2 system appears central to the 28	
development of enhanced motivation for morphine. Mice lacking D2 DA receptors equally pursue morphine and 29	
saline infusions on FR or PR schedules [89]; however, rodents with increased proenkephalin gene expression in 30	
	 15	
the NAcc and DS demonstrate significantly higher breakpoints for morphine infusion than wild-type animals 1	
[90]. Thus, converging neurobiological evidence identifies both dopaminergic and opioid systems in the 2	
maintenance of opiate seeking. Over time, these neurobiological changes lead to the loss of control over drug 3	
seeking and intake, resulting in the hallmark feature of addiction—habitual drug seeking. 4	
Sugar: 5	
Enhanced motivation and sugar seeking is often achieved by forced deprivation, which has increased 6	
the number of lever presses for self-administration of sucrose solution [16]. However, these findings do not 7	
directly represent rodents’ motivation for a sugar reward but rather the number of unsuccessful lever presses 8	
executed under an FR1 schedule (i.e., the lever presses in between sugar receipt). Receipt of sugar reward was 9	
not dependent upon the number of additional presses between reinforcement. A more recent study has 10	
incorporated differential reinforcement schedules, which systematically increase the time intervals between 11	
sucrose reinforcements to quantify impulsive responding for sucrose solutions [91]; however, the findings failed 12	
to demonstrate increased lever pressing across sucrose-reinforced sessions as compared to control (i.e., water) 13	
sessions. As such, motivation for sucrose appears to be less robust than that for either cocaine or heroin, though 14	
expectedly infusion of a selective mu-opioid agonist significantly increases break points for sugar pellets in a 15	
progressive ratio schedule [92].  16	
Some research has quantified motivation for sucrose by direct comparison with other drug-seeking 17	
behaviours. In one study, some rodents preferred self-administration of saccharin over cocaine and paid a 18	
greater ‘price’ for saccharin than for cocaine by adhering to FR2, FR4, and FR8 reinforcement schedules [54]. 19	
Although this resembles early PR schedules in which rodents linearly increased lever presses for subsequent 20	
infusions, standard PR schedules for drug reinforcement now require rats to increase lever presses exponentially 21	
from one infusion to the next [56]. Thus, direct comparison of these findings to those from PR schedules of 22	
cocaine and heroin reinforcement overestimates the degree to which saccharin increases motivation. Rodents 23	
bred for high-saccharin selectivity increased cocaine consumption following reinstatement of drug-seeking 24	
behaviour, yet the effect(s) of sweet-preference on vulnerability to drug addiction remain poorly understood 25	
[93]. For example, preference for Oreo cookies has predicted greater break points on a PR schedule for IV 26	
cocaine infusion, yet, rodents that preferred rice cakes demonstrated equivalent self-administration, tolerance, 27	
and reinstatement of cocaine-seeking behaviour [94].  28	
4.3. Habitual use and withdrawal: 29	
Drugs: 30	
	 16	
Rodents with extended cocaine self-administration training preferentially return to environments in which 1	
cocaine was administered, even following periods of abstinence (see [95, 96]). Exposure to the conditioned 2	
stimulus (i.e., a light previously paired with lever pressing) has been shown to reinstate cocaine-seeking 3	
behaviour [49] and morphine administration [50] following abstinence. A combination of drug priming, or drug 4	
injections following abstinence, and the CPP paradigm restores habitual cocaine and heroin [51] seeking 5	
behaviour, thus modelling the circumstances under which humans often experience drug relapse. 6	
Whereas the acute reinforcing effects of cocaine are associated with increased extracellular DA in the VS 7	
and NAcc shell, cocaine seeking has been related to enhanced DA in the DS independent of the NAcc [97]. 8	
Blockade of DA receptors in the anterior dorsolateral striatum, but not the pDMS or NAcc, decreases drug 9	
seeking [98]. Jedynak and colleagues [99] further demonstrated that prolonged stimulant use alters synaptic 10	
connectivity in DS neurons by increasing dendritic spine density in the dorsolateral subregion and decreasing 11	
spine density in the dorsomedial subregion. The authors assert that such restructuring of synaptic connectivity in 12	
the DS underlies the emergence of S-R habits following chronic stimulant use as the dorsolateral striatum gains 13	
control of these behaviours. As discussed above, in the case of heroin, the opponent processes model describes 14	
the persistence of drug use as negatively reinforced by the dysphoria of withdrawal symptoms [100]. 15	
Sugar: 16	
Although compulsive sugar-seeking behaviour following extended consumption has yet to be studied 17	
explicitly, converging evidence suggests that animals develop CPP in response to food rewards. After abstaining 18	
from sugar, food-deprived rodents prefer the environments in which 12% and 20% sucrose solutions were 19	
consumed [101, 102], and similar findings were reported with high-sucrose food rewards [103]. Administration 20	
of naltrexone dose-dependently disrupts CPP for sucrose, yet the opioid antagonist does not affect the 21	
development of CPP [104]. The competitive opioid antagonist naloxone precipitates withdrawal symptoms in 22	
sugar-bingeing rats, which resemble those of opiate withdrawal (e.g., anxiety, teeth chattering, forepaw tremor, 23	
head shakes) and share a similar neural profile with decreased DA and increased acetylcholine in NAcc [67]. 24	
Furthermore, Avena et al. [105] report increased anxiety in fasted rodents (36 hours) that were previously 25	
maintained on an extended intermittent reinforcement schedule with 10% sucrose solution. A similar withdrawal 26	
syndrome has been observed following 8 days of an intermittent access to saccharin [52]. It has also been 27	
demonstrated that rats on the intermittent access schedule show reduced D2 DA receptor binding in the DS [67]. 28	
4.4.  A shared neurobiology? 29	
	 17	
 An oft-repeated observation asserts that food and drug consumption share a common neurobiology 1	
[106]. This is true in so far as drugs are understood to ‘hijack’ a neural system that primarily processes natural 2	
rewards like foods; however, certain important differences remain. First is the matter of the anatomical 3	
localisation of the neural circuits involved in these consummatory behaviours. Carelli et al. [107] have 4	
demonstrated that different populations of neurons in the NAcc respond to cocaine and natural rewards. Second, 5	
the dopaminergic response to sugar (and other foods) rapidly habituates, and it is attenuated by predictive cues 6	
such as smells; however, the DA response to cocaine does not habituate and is enhanced by predictive cues [32]. 7	
Third, when cue pairing to the delivery of either sugar or cocaine is established, the cue results in a 8	
dopaminergic surge. Importantly, in the case of sucrose, the DA level rapidly returns to baseline and does not 9	
rise again with lever pressing or consumption of sucrose [108] whereas, in cocaine, the surge does not return to 10	
baseline but further increases after lever pressing and cocaine delivery [109]. Fourth, Pavlovian stimuli 11	
conditioned to food release DA in the NAcc core whereas those conditioned to drugs of abuse release DA in the 12	
shell [110][55].  13	
4.5. Summary of the animal neuroscience: 14	
 Clearly, addiction-like behaviours can be elicited by sucrose but there are two important caveats to bear 15	
in mind. First, as evidenced by the studies using sucrose in sham-fed animals, and those that used real feeding 16	
with saccharin, it seems that these behaviours occur in response to the palatability of sweet tastants, not the 17	
caloric content. Both these findings raise another important question. Are there any pharmacodynamic effects of 18	
sucrose that are important to the development of this addiction syndrome, in the way that pharmacodynamic 19	
effects of drugs are critical to the development of the neuroadaptive changes of addiction? Second, these 20	
behaviours are only engendered in a specific intermittent access regime, which seems critical to their 21	
development, as these behaviours are not seen in animals given ad libitum access to sugar. Moreover, within 22	
this regime, test animals have been pre-selected for sucrose preference. This practice has become largely 23	
obsolete in animal models of drug addiction where drug-naïve animals are preferable. By excluding sucrose-24	
naïve animals, the prevalence of addictive-like sucrose consumption remains unknown as opposed to cocaine or 25	
heroin addiction, where it has been estimated that between 5% and 24% of individuals who use drugs go on to 26	
develop drug addiction [111–113]. Clearly, the combination of sweet taste and intermittent access can trigger a 27	
state that strongly resembles addiction in several aspects, including a cross-sensitisation effect to amphetamine 28	
and alcohol [69, 114] that seems to be mediated by mu-opioid receptor binding. 29	
	 18	
However, even in the intermittent access model, there remain several key deficiencies in the case for a 1	
sugar addiction. To date, increased motivation for sucrose has been poorly modelled because few studies have 2	
implemented progressive ratio schedules to measure the rodents’ willingness to work for sugar. Rodents with 3	
extended access to sugar remain susceptible to devaluation procedures, such as the addition of a nausea-4	
inducing agent, whereas cocaine- or heroin-addicted animals continue to pursue the drug despite negative 5	
consequences. The extent of habitual responding to sugar remains understudied, and the effect of CPP on 6	
reinstatement of sucrose seeking has yet to be characterised. In contrast, the presentation of conditioned stimuli 7	
reliably reinstates drug-seeking behaviours in animals with historic cocaine or heroin use, and the reinstatement 8	
of habitual drug-seeking in response to environmental cues represents a hallmark feature of addiction. Taken 9	
together, addictive-like consumption of sugar diverges from drug addiction on both neurobiological and 10	
behavioural levels, suggesting a need for great caution in drawing parallels between sugar and drug addiction.  11	
5. Sugar addiction in humans 12	
There has been little empirical work examining sugar addiction in humans. Given this, we consider how 13	
sugar addiction, as a specific form of FA, might be conceptualised in humans, and we summarize experimental 14	
challenges in evaluating it, beginning with a brief overview of FA. 15	
5.1. The behavioural phenotype of food addiction: the YFAS and YFAS 2.0 16	
The current FA phenotype was first operationalized in the 25-item Yale Food Addiction Scale (YFAS; 17	
[13]). Both the FA model and the YFAS conceptualised FA in terms of a translation of DSM-IV substance 18	
dependence [115] to food. Criteria include: persistent eating despite negative consequences, persistent desire for 19	
food and unsuccessful attempts to cut down and impairment of functioning because of overeating. The criteria 20	
are defined with respect to ‘certain foods,’ and the YFAS provides 21 examples from 5 food categories: sweets 21	
(e.g. ice cream), starches (French fries), salty snacks (pretzels), fatty foods (pizzas) and sugary drinks. The 22	
YFAS can provide a ‘diagnosis’ of FA if at least three criteria are endorsed along with clinical impairment, or a 23	
‘symptom count’ to indicate severity of symptomology (scores range from 0 to 7). It has become a popular and 24	
widely used self-report measure of this construct to the extent that it is used to both define and measure FA, 25	
though its validity and utility have been questioned [10, 11]. 26	
The YFAS has recently been updated [14] based on DSM-5 criteria for substance-related and addictive 27	
disorders in the YFAS 2.0. The key difference is that, in updating criteria according to DSM-5, which 28	
incorporates both abuse and dependence, the threshold for diagnosing FA has been reduced. As such, 29	
individuals experiencing clinically significant impairment may be diagnosed with mild (2 – 3 symptoms), 30	
	 19	
moderate (4 – 5 symptoms), or severe (6 or more symptoms) FA. Preliminary validation of the YFAS 2.0 1	
estimates that 15.8% of individuals meet criteria for FA, and 11.9% of the sample met the threshold for severe 2	
FA. As with the YFAS, overweight and obese individuals endorsed more FA symptoms than their lean 3	
counterparts, and the prevalence rate of severe FA was highest in the obese weight class [14]. Although the 4	
authors report improved internal consistency and convergent validity in the YFAS 2.0, previously-expressed 5	
concerns (see [11, 116]) regarding the inclusion of withdrawal symptoms and tolerance and how they might 6	
relate to foods remain. With respect to these, the main concern is not that their presence is critical in FA; rather, 7	
their inclusion in the scale is undermined by the fact that they are not adequately defined and may therefore 8	
mean different things to different respondents. Moreover, withdrawal is frequently endorsed by participants in 9	
several YFAS studies, and from the development study of the YFAS 2.0, there seems to be strong concordance 10	
between the withdrawal items in the YFAS and the YFAS 2.0 [14]. It is important, therefore that they are 11	
characterized clearly and rigorously. Given the lack of precise definition, it is difficult to determine conclusively 12	
that endorsement of this item reflects withdrawal symptoms to a particular nutrient or food. Indeed, if a 13	
withdrawal syndrome could be rigorously characterised, it would offer important clues as to the nature and 14	
mechanism of action of the addictive substance. However, here it is important to acknowledge the difficulty 15	
posed by the lack of a clearly defined addictive agent or food. 16	
5.2 Does food addiction represent a distinct phenotype? 17	
FA has several shared features and high levels of co-morbidity with binge eating disorder (BED) [10, 117], 18	
which raises the question: could it be that YFAS is indirectly measuring a syndrome already well described as 19	
opposed to defining a distinct syndrome? BED is characterised by the consumption of objectively large portions 20	
of food with loss of control over eating, which is often done in isolation and followed by feelings of guilt and 21	
disgust. It is associated with weight gain, but a significant proportion of people with BED are not obese. Patients 22	
with BED have been proposed to be the strongest candidates for FA [118], and some researchers have proposed 23	
that FA represents an atypical subtype of BED based on a growing body of literature that has identified shared 24	
genetic vulnerabilities to drug abuse and binge eating. Others have suggested that individuals with BED exhibit 25	
poor impulse control and emotion regulation, as well as aberrant reward processing, which may increase FA 26	
liability [119]. Davis et al. [120] found that BED was associated with the A118 polymorphism of the mu-opioid 27	
receptor gene (OPRM1) and the Taq1A A1 polymorphism of the dopamine D2 receptor gene (DRD2), both risk 28	
factors for substance use disorder. This same group also identified a dopaminergic multilocus genetic profile 29	
that is uniquely associated with FA when controlling for binge eating behaviours [121]. These data suggest a 30	
	 20	
similarity between FA and substance addictions, but require further exploration in well-powered studies with the 1	
appropriate diagnostic groups is necessary.  2	
 Long and colleagues recently carried out the first systematic review of the YFAS literature [117]. They 3	
examined 40 published articles to address important outstanding questions about FA, including its relationship 4	
with BMI and eating disorder pathology and whether FA represents a distinct phenotype of disordered eating. 5	
The authors found a high co-occurrence of FA with BED and bulimia nervosa. An estimated 47.2% to 56.8% of 6	
people with BED meet criteria for a FA “diagnosis” [117], and these prevalence rates seem excessive for a 7	
diagnostic subgroup. Binge-eating frequency correlated with YFAS scores in both overweight and healthy 8	
weight groups, but the relationship with BMI was less clear-cut.  Some studies report non-significant differences 9	
in BMI across YFAS-diagnosed “food addicts” and their healthy counterparts [122] while others indicate no 10	
correlation between BMI and YFAS score [123, 124]. While the prevalence rates of FA are consistently greater 11	
in overweight and obese groups (15.2% to 56.8%), whether FA accounts for enough unique variance in obesity 12	
to be considered an explanatory mechanism for this condition remains unclear. Furthermore, the highest 13	
prevalence rates of FA have been reported in individuals with bulimia nervosa (83.6%) [125, 126]. This finding 14	
should be interpreted cautiously as the numbers of individuals with diagnosed bulimia nervosa in these studies 15	
is small. Nevertheless, as these individuals often maintain a healthy BMI, it remains plausible that FA 16	
prevalence could be dissociable from BMI, particularly amongst those who have distorted thoughts related to 17	
food consumption. In summary, the findings of Long et al. [117] provide evidence of significant heterogeneity 18	
in the behavioural correlates of FA and suggest poor discriminant validity of the YFAS.   19	
5.3. Defining a sugar addiction in humans  20	
Defining sugar addiction in humans remains challenging. First, as we have discussed earlier, little 21	
evidence supports sugar as an addictive substance, and the animal neuroscience literature suggests sweetness or 22	
palatability to be critical elements of addictive-like eating. That is, sweet foods rather than sugar per se might be 23	
the ‘substance’ of interest. Even so, there remain important questions about how sweetness or sugar content 24	
relates to addictive potential and whether sugar is necessary. Second, current measurement of FA is 25	
insufficiently precise and, given a commonplace behaviour like consumption of sweet food, it will be critical to 26	
define a profile of consumption that separates normal from disordered intake. The YFAS attempts to do this by 27	
using severity criteria for individual items and a necessary overall impairment criterion for diagnosis [13]. 28	
Although preliminary, examination of dietary profiles associated with problematic eating in young adults has 29	
shown that consumption of energy-dense, nutrient-poor foods (e.g., candy, take out meals) is positively 30	
	 21	
correlated with FA score and BMI [127]. Interestingly, dietary intake of carbohydrates or sugar was not 1	
significantly associated with FA diagnoses or scores, suggesting a limited role of sugar in putative addictive-like 2	
eating in humans. Third, whether FA represents a distinct phenotype remains unclear, and the high degree of 3	
diagnostic overlap with BED is a particular difficulty. Distinguishing individuals with BED who preferentially 4	
binge on sweet foods from those with a sugar (or sweet food) addiction will be a challenging yet critical step 5	
toward a more refined FA phenotype.  6	
 An alternative approach would be to consider whether aspects of sugar or sweet food consumption 7	
share a similarity with addiction-like behaviours, such as cravings (for a review, see [55]). The general 8	
population often reports food cravings, particularly for palatable foods like chocolate. However, these cravings 9	
differ from drug cravings in terms of their intensity, their reported frequency and/or their duration. Food 10	
cravings are relatively short-lived and subside with fasting as opposed to drug cravings, which persist and do 11	
not lessen in intensity with abstinence [55, 128]. Rogers and Smit [128] have proposed an alternative 12	
formulation: seeing food cravings in terms of ambivalent attitudes to particular foods. Thus, for some people, 13	
chocolate is a highly desirable food but one that should be eaten with restraint. Attempts to restrain intake make 14	
chocolate more salient and preoccupying, and this is experienced as a craving and hence, perhaps, likened to an 15	
addiction. In part, this alternative approach asks if there is an addictive aspect to normal eating (of sweet foods), 16	
and this is highly debatable.  17	
6. Conclusions  18	
In this perspective article, we have reviewed the current state of the evidence for sugar addiction. Most 19	
of the evidence is limited the animal neuroscience literature, and it is far from convincing. Importantly, several 20	
key elements of drug addiction have not been evaluated in sugar addiction models, such as the transition to 21	
compulsive drug taking and dose-dependent effects on addiction liability. There remains a paucity of human 22	
evidence in this area, and we did not consider the literature encompassing the behavioural and neural effects of 23	
sweet or palatable food consumption as this would be far too indirect to the question of sugar addiction. There is 24	
the problem of the dearth of data on pure sugar consumption as we rarely consume sugar in isolation, and the 25	
ecological validity of studies examining pure sugar consumption in humans would be limited.  26	
In terms of future directions, we suggest two areas of potential interest. The first is to examine whether 27	
sweet foods with high GI/GL might cause a food addiction in humans. We have discussed the significant 28	
methodological and conceptual limitations of the human FA model and its measurement instruments, the YFAS 29	
and the YFAS 2.0, which will need to be considered in such explorations. The second is to examine the 30	
	 22	
relevance of the intermittent sugar access schedule used in animal models to the development of eating disorders 1	
(and perhaps even a form of FA) in humans.  2	
In summary, the science of sugar addiction at present is not compelling. Nevertheless, sugar addiction 3	
remains a very popular and powerful idea, but as this special issue illustrates, it is by no means alone in this 4	
regard when it comes to misconceptions about sugar. Even the most perfunctory internet search reveals how 5	
much emotive and explanatory power the term ‘sugar addiction’ has when used in its lay sense for individuals 6	
personally, as well as in the context of major public debates such as those over the sugar tax or campaigns such 7	
as Action on Sugar in the UK. Although the concept as we discuss it here is far more rigorous, the lay 8	
interpretation raises the question of whether sugar addiction is a useful (if not valid) concept to help tackle 9	
obesity and/or change the food environment? From a policy perspective, it is unlikely that sugar could be 10	
excluded from individuals’ diets given its presence in numerous food items, and any analogies suggested based 11	
on the regulation of illicit drugs would be specious. Given the multitude of interacting factors that increase 12	
one’s risk for eating disorders and obesity, we argue that support of sugar addiction as a primary causal 13	
mechanism of weight gain represents an extremely narrow view that fails to capture the complexity of these 14	
conditions, and one that may hamper more coordinated and appropriate responses. Furthermore, while there is a 15	
pressing need to address these important concerns, we argue that it is dangerous to draw strong conclusions 16	
about the validity of sugar addiction based on the current evidence. There are many strong arguments for cutting 17	
down the consumption of sugar and reformulating food products accordingly, yet these arguments will all stand 18	
or fall according to the scientific case that supports them.  19	
 20	
  21	
	 23	
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